Next Article in Journal
Next Article in Special Issue
Previous Article in Journal
Previous Article in Special Issue
Pharmaceuticals 2010, 3(4), 1084-1092; doi:10.3390/ph3041084
Review

Non Steroidal Anti-Inflammatory Drugs and Inflammatory Bowel Disease

 and *
Received: 13 January 2010; in revised form: 1 April 2010 / Accepted: 9 April 2010 / Published: 12 April 2010
(This article belongs to the collection Non-Steroidal Anti-Inflammatory Drugs)
View Full-Text   |   Download PDF [155 KB, uploaded 12 April 2010]
Abstract: Inflammatory Bowel Diseases (IBD) are an immune mediated chronic or relapsing disorders of the gastrointestinal (GI) tract. IBD is characterized by a chronic intestinal inflammatory process with various components contributing to the pathogenesis of the disease including environmental factors such as smoking or use of Non Steroidal Anti-Inflammatory Drugs (NSAIDS). NSAIDS are among the most commonly used medications for the treatment of various inflammatory conditions. The main factor limiting NSAIDS use is the concern for the development of gastrointestinal toxicity including mucosal injury. A possible association between the use of NSAIDS and the onset or relapse of IBD has been repeatedly suggested. This article will review the current concepts and evidence of the relationship between IBD and NSAIDS.
Keywords: NSAIDs; IBD; Crohn's; Ulcerative Colitis NSAIDs; IBD; Crohn's; Ulcerative Colitis
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Klein, A.; Eliakim, R. Non Steroidal Anti-Inflammatory Drugs and Inflammatory Bowel Disease. Pharmaceuticals 2010, 3, 1084-1092.

AMA Style

Klein A, Eliakim R. Non Steroidal Anti-Inflammatory Drugs and Inflammatory Bowel Disease. Pharmaceuticals. 2010; 3(4):1084-1092.

Chicago/Turabian Style

Klein, Amir; Eliakim, Rami. 2010. "Non Steroidal Anti-Inflammatory Drugs and Inflammatory Bowel Disease." Pharmaceuticals 3, no. 4: 1084-1092.



Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert